UBS Group’s Ambev ABEV Stock Holding History

UBS Group’s Portfolio ABEV Stock Details ABEV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-437,600	Closed	-$1.16M	–	7929
2020 Q2	$1.16M	Buy	+437,600	New	+$1.03M	﹤0.01%	3386
2019 Q2	–	Sell	-320,700	Closed	-$1.38M	–	7820
2019 Q1	$1.38M	Sell	320,700 -806,600	-72%	-$3.7M	﹤0.01%	3318
2018 Q4	$4.42M	Buy	1,127,300 +959,200	+571%	+$4.09M	﹤0.01%	2263
2018 Q3	$768K	Buy	+168,100	New	+$801K	﹤0.01%	4077
2017 Q1	–	Sell	-116,000	Closed	-$570K	–	7588
2016 Q4	$570K	Buy	+116,000	New	+$626K	﹤0.01%	4016
2015 Q2	–	Sell	-628,000	Closed	-$3.62M	–	8442
2015 Q1	$3.62M	Buy	628,000 +568,400	+954%	+$3.53M	﹤0.01%	2369
2014 Q4	$371K	Buy	+59,600	New	+$376K	﹤0.01%	4461

Other funds holding ABEV

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCP

Seafarer Capital Partners Larkspur, California $436M AUM 42.05% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group's ABEV Position: Q1 2026 in Review

UBS Group increased its Ambev (ABEV) stake by 14% in Q1 2026, buying an estimated $2.26M and bringing the position to 6,550,266 shares worth $19.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2645.

UBS Group first reported a position in ABEV in Q4 2014 and has held it in 46 quarters since. The position peaked at $33.7M in Q1 2025. 403 funds tracked by Wall St. Rank hold ABEV as of Q1 2026.

UBS Group held 6,550,266 shares of Ambev worth $19.1M as of Q1 2026.
UBS Group bought 792,049 Ambev shares in Q1 2026, an estimated $2.26M.
Ambev made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #2645 holding.
UBS Group first reported a position in Ambev in Q4 2014 and has held it in 46 quarters since.
UBS Group's Ambev position peaked at $33.7M in Q1 2025.
403 funds tracked by Wall St. Rank held Ambev as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.